These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19714203)

  • 1. Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2009 Aug; 5(8):e1000487. PubMed ID: 19714203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases.
    Dixit A; Verkhivker GM
    PLoS Comput Biol; 2011 Oct; 7(10):e1002179. PubMed ID: 21998569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
    Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution.
    Badger J; Grover P; Shi H; Panjarian SB; Engen JR; Smithgall TE; Makowski L
    Biochemistry; 2016 Jun; 55(23):3251-60. PubMed ID: 27166638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.
    Sutto L; Gervasio FL
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10616-21. PubMed ID: 23754386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.
    Tse A; Verkhivker GM
    J Chem Inf Model; 2015 Aug; 55(8):1645-62. PubMed ID: 26236953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of EGFR point mutations on the sensitivity to gefitinib: insights from comparative structural analyses and molecular dynamics simulations.
    Liu B; Bernard B; Wu JH
    Proteins; 2006 Nov; 65(2):331-46. PubMed ID: 16927343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational disturbance in Abl kinase upon mutation and deregulation.
    Iacob RE; Pene-Dumitrescu T; Zhang J; Gray NS; Smithgall TE; Engen JR
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1386-91. PubMed ID: 19164531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of tyrosine kinases by mutation of the gatekeeper threonine.
    Azam M; Seeliger MA; Gray NS; Kuriyan J; Daley GQ
    Nat Struct Mol Biol; 2008 Oct; 15(10):1109-18. PubMed ID: 18794843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.
    Dixit A; Torkamani A; Schork NJ; Verkhivker G
    Biophys J; 2009 Feb; 96(3):858-74. PubMed ID: 19186126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the allosteric inhibition of Abl kinase.
    Fallacara AL; Tintori C; Radi M; Schenone S; Botta M
    J Chem Inf Model; 2014 May; 54(5):1325-38. PubMed ID: 24787133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abl N-terminal cap stabilization of SH3 domain dynamics.
    Chen S; Dumitrescu TP; Smithgall TE; Engen JR
    Biochemistry; 2008 May; 47(21):5795-803. PubMed ID: 18452309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor.
    Zhu G; Decker SJ; Mayer BJ; Saltiel AR
    J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion.
    Dölker N; Górna MW; Sutto L; Torralba AS; Superti-Furga G; Gervasio FL
    PLoS Comput Biol; 2014 Oct; 10(10):e1003863. PubMed ID: 25299346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications.
    Astl L; Verkhivker GM
    J Chem Theory Comput; 2019 May; 15(5):3362-3380. PubMed ID: 31017783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Mutation-Induced Allosteric Changes in Structures and Conformational Ensembles of the ABL Kinase Using AlphaFold2 Adaptations with Alanine Sequence Scanning.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and Experimental Characterization of Patient Derived Mutations Reveal an Unusual Mode of Regulatory Spine Assembly and Drug Sensitivity in EGFR Kinase.
    Ruan Z; Katiyar S; Kannan N
    Biochemistry; 2017 Jan; 56(1):22-32. PubMed ID: 27936599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.